HK Stock Movement | BIOSTAR PHARM-B (02563) Plunges Over 37% as Major Share Unlock Hits Post One-Year Listing
Stock News
Oct 31
BIOSTAR PHARM-B (02563) saw its shares plummet more than 37% intraday. At press time, the stock was down 29.98% to HK$3.55, with a turnover of HK$5.82 million. The sharp decline followed the expiration of its one-year listing lock-up period, releasing approximately 246 million restricted shares into the market.
In the first half of this year, BIOSTAR PHARM-B reported revenue of RMB14.79 million, down 55.36% year-on-year. Net losses narrowed by 23.41% to RMB54.04 million, with a basic loss per share of RMB0.15.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.